In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA-approved filter debuts in Revitalift

This article was originally published in The Rose Sheet

Executive Summary

L'Oréal's newly launching Revitalift UV Daily Moisturizing Cream with Mexoryl SX is the first item in the U.S. containing Mexoryl SX (ecamsule), a moisturizer that protects against short- and long-wave UVA radiation and has just been approved by FDA, the company announces Oct. 15. The filter has been used in Europe for 13 years; the item offers UVA protection as well as SPF 15 (UVB) coverage, according to L'Oréal, which pegs UVA radiation as the primary cause of skin aging and a major contributor to the development of skin cancer. The cream is available at drug and mass doors...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel